David Sackel is an Ophthalmology physician. OpenAlex indexes 9 publications with 498 citations (h-index 4).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
5995 Barfield Rd
Thomas Eye Group
Atlanta, GA 303284411
Telephone
678-892-2020Provider last certified this registry record 21 Oct 2021.
Industry payments
33 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Sight Sciences, Inc.Program year20252 payments
- BIOTISSUE HOLDINGS INC.Program year20257 payments
- LENSAR, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
49.3%Corticosteroid25%Prednisolone Acetate94%Fluorometholone4%Flarex3%Part D<11 patientsProstaglandin Analog11.6%Latanoprost88%Lumigan12%Part D<11 patients+ 4 more classes in this area
Anti-infectives
29.5%Fluoroquinolone Antibacterial15.5%Moxifloxacin100%Part D≥144 patientsMacrolide7.1%Erythromycin100%Part D≥51 patients+ 2 more classes in this area
Cancer & immunology
7.5%Calcineurin inhibitor7.5%Restasis47%Cequa23%Vevye16%Cyclosporine15%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Physician Survey for Study of Suppressive Antiviral Treatment to Reduce Chronic Ocular Disease and Postherpetic Neuralgia After Herpes Zoster Ophthalmicus
Eye & Contact Lens Science & Clinical Practice
2014 - F116 Methodology and Pearls Implementing Ocular Scatter Quantification in Evaluation of Refractive Surgery
The Annual ASCRS and ASOA Symposium and Congress
2014 - Long-Term 3-Dimensional Post-LASIK Epithelial Thickness Change and Remodeling
The Annual ASCRS and ASOA Symposium and Congress
2014 - Microbial patient and operating room personnel sampling and culture evaluation of an ambulatory ophthalmological unit. A novel protocol.
Investigative Ophthalmology & Visual Science
2014 - Use of a Retinal Acuity Meter (RAM) and Brightness Acuity Meter (BAM) to Identify Early Diabetic Macular Edema
Investigative Ophthalmology & Visual Science
2013
Similar KOLs
Other experts from the same institution or the same specialty.
Ali Bijani
Babol University of Medical Sciences
Hamid Asayesh
Ayatollah Boroujerdi University
John J. Huang
Isfahan University of Medical Sciences
Fotis Topouzis
National University of Singapore
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”